Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension

Journal of Hepatology

Volumn 60, Issue 5, 2014, Pages 1040-1045

  Sung, Ki Chul ^a   Wild, Sarah H ^b   Byrne, Christopher D ^c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Hypertension; Insulin resistance; Metabolic syndrome; Non alcoholic fatty liver disease; Obesity; Type 2 diabetes

Indexed keywords

ADULT; COHORT ANALYSIS; COMPLICATION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SOUTH KOREA;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; RECURRENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84898816572     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.01.009     Document Type: Article

References (21)

1. A. Lopez-Suarez, J.M. Guerrero, J. Elvira-Gonzalez, M. Beltran-Robles, F. Canas-Hormigo, and A. Bascunana-Quirell Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase Eur J Gastroenterol Hepatol 23 2011 1011 1017
2. G. Donati, B. Stagni, F. Piscaglia, N. Venturoli, A.M. Morselli-Labate, and L. Rasciti et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance Gut 53 2004 1020 1023
3. K. Lau, R. Lorbeer, R. Haring, C.O. Schmidt, H. Wallaschofski, and M. Nauck et al. The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study J Hypertens 28 2010 1829 1835
4. K. Hallsworth, K.G. Hollingsworth, C. Thoma, D. Jakovljevic, G.A. MacGowan, and Q.M. Anstee et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease J Hepatol 58 2013 757 762
5. K.G. Hollingsworth, A.M. Blamire, B.D. Keavney, and G.A. Macgowan Left ventricular torsion, energetics, and diastolic function in normal human aging Am J Physiol Heart Circ Physiol 302 2012 H885 H892
6. S.H. Santos, and E.S.A.C. Simoes The therapeutic role of renin-angiotensin system blockers in obesity-related renal disorders Curr Clin Pharmacol 2012 [Epub ahead of print]
7. A.L. Ahn, J.K. Choi, M.N. Kim, S.A. Kim, E.J. Oh, and H.J. Kweon et al. Non-alcoholic fatty liver disease and chronic kidney disease in Koreans aged 50 Years or older Korean J Fam Med 34 2013 199 205
8. G. Targher, L. Bertolini, M. Chonchol, S. Rodella, G. Zoppini, and G. Lippi et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients Diabetologia 53 2010 1341 1348
9. G. Targher, M. Chonchol, L. Bertolini, S. Rodella, L. Zenari, and G. Lippi et al. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease J Am Soc Nephrol 19 2008 1564 1570
10. A.S. Levey, J. Coresh, E. Balk, A.T. Kausz, A. Levin, and M.W. Steffes et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2003 137 147
11. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, and M. Hurley et al. The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 2002 745 750
12. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, and K.A. Donato et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
13. K.C. Sung, S.H. Wild, and C.D. Byrne Resolution of fatty liver and risk of incident diabetes J Clin Endocrinol Metab 98 2013 3637 3643
14. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, and M. Lenzi et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850
15. M. Bombelli, R. Facchetti, R. Sega, S. Carugo, D. Fodri, and G. Brambilla et al. Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage Hypertension 58 2011 1029 1035
16. H.M. Shihab, L.A. Meoni, A.Y. Chu, N.Y. Wang, D.E. Ford, and K.Y. Liang et al. Body mass index and risk of incident hypertension over the life course: the johns hopkins precursors study Circulation 126 2012 2983 2989
17. R. Nyamdorj, Q. Qiao, S. Soderberg, J. Pitkaniemi, P. Zimmet, and J. Shaw et al. Comparison of body mass index with waist circumference, waist-to-hip ratio, and waist-to-stature ratio as a predictor of hypertension incidence in Mauritius J Hypertens 26 2008 866 870
18. C.C. Tyson, L.J. Appel, W.M. Vollmer, G.J. Jerome, P.J. Brantley, and J.F. Hollis et al. Impact of 5-year weight change on blood pressure: results from the weight loss maintenance trial J Clin Hypertens (Greenwich) 15 2013 458 464
19. G. Targher, M. Chonchol, G. Zoppini, C. Abaterusso, and E. Bonora Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol 54 2011 1020 1029
20. Y.C. Liu, C.S. Hung, Y.W. Wu, Y.C. Lee, Y.H. Lin, and C. Lin et al. Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability PLoS One 8 2013 e61803
21. J.L. Newton, J. Pairman, K. Wilton, D.E. Jones, and C. Day Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease Clin Auton Res 19 2009 319 326